MG
NBEV

Michael Gelband’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Michael Gelband’s Portfolio NBEV Stock Details NBEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-34,845
Closed -$48K – 2772
2021
Q3 		$48K Buy
34,845
+19,446
+126% +$35.4K ﹤0.01% 1974
2021
Q2 		$34K Buy
+15,399
New +$35.9K ﹤0.01% 2245
2020
Q1 		– Sell
-185,378
Closed -$337K – 1814
2019
Q4 		$337K Buy
+185,378
New +$439K 0.01% 1088
2019
Q2 		– Sell
-77,223
Closed -$406K – 1411
2019
Q1 		$406K Buy
77,223
+19,123
+33% +$115K 0.03% 386
2018
Q4 		$302K Buy
+58,100
New +$305K 0.02% 195

Other funds holding NBEV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Michael Gelband's NBEV Position: Q4 2021 in Review

Michael Gelband sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q4 2021, closing a stake of 34,845 shares — an estimated $48K sold.

Michael Gelband first reported a position in NBEV in Q4 2018 and held it in 5 quarters. The position peaked at $406K in Q1 2019. 98 funds tracked by Wall St. Rank hold NBEV as of Q4 2021.

  • Michael Gelband reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q4 2021 after selling out during the quarter.
  • Michael Gelband sold 34,845 NewAge, Inc. Common Stock (Delaware) shares in Q4 2021, an estimated $48K.
  • Michael Gelband first reported a position in NewAge, Inc. Common Stock (Delaware) in Q4 2018 and held it in 5 quarters.
  • Michael Gelband's NewAge, Inc. Common Stock (Delaware) position peaked at $406K in Q1 2019.
  • 98 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.